胃食道逆流症治療器市場：製品タイプ、手技タイプ、手術タイプ、デバイスタイプ、剤形、投与経路、エンドユーザー別-2025-2030年世界予測

胃食道逆流症治療器市場は、2023年に58億5,000万米ドルと評価され、2024年には66億5,000万米ドルに達すると予測され、CAGR 13.66％で成長し、2030年には143億5,000万米ドルに達すると予測されます。

胃食道逆流症（GERD）機器市場は、胃酸の食道への逆流によって胸焼けや酸の逆流といった症状を引き起こすGERDの診断と治療を目的とした医療機器を包括しています。これらの医療機器の必要性は、ライフスタイルの変化、肥満、食生活などの要因により、GERDの有病率が増加していることにあります。その用途は、診断用内視鏡検査、酸曝露のpHモニタリング、磁気括約筋増強術、高周波焼灼術に及び、軽度から重度の逆流症状まで患者のニーズに対応しています。最終用途分野には、低侵襲ソリューションへの需要が高まっている病院、外来手術センター、専門クリニックなどが含まれます。主な成長要因としては、内視鏡手術の進歩、GERD合併症に対する意識の高まり、機器導入を後押しするヘルスケア政策などが挙げられます。市場機会は、機器の精度や患者の快適性に関する技術革新や、ヘルスケアインフラが整備されつつある新興市場での地理的拡大によって拡大しています。こうした機会を捉えるため、企業は非侵襲的診断・治療法の研究開発、カスタマイズされた機器設計、世界の普及を目指す戦略的パートナーシップに注力すべきです。しかし、先進的な機器の高額なコスト、厳しい規制当局の承認、薬物療法や生活習慣の改善といった代替治療法の利用が可能であることなどが、機器の普及を阻害する可能性があるため、市場は限界に直面しています。イノベーションは、費用対効果が高く患者に優しい診断ツールの開発や、GERDモニタリング・ソリューションのためのAIや機械学習の開発に向けられる可能性があります。市場は競合が多く、各社は製品の差別化と患者のアウトカムを重視しているため、各社は継続的にイノベーションを行い、ヘルスケア・プロバイダーのニーズに合わせることが重要です。GERD管理に関する教育的イニシアチブを開拓することで、エンドユーザーの認識を高め、市場浸透を促進し、GERD機器分野全体の成長を促進することができます。

市場力学：急速に進化する胃食道逆流症治療器市場の主要市場インサイトを公開

胃食道逆流症治療器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の高齢化人口の増加
  • 肥満人口の増加と手術嗜好の高まり
  • 診断センターや民間クリニックでの採用急増
• 市場抑制要因
  • プロトンポンプ阻害薬などの代替薬の入手可能性
• 市場機会
  • 市場における技術革新と新製品投入の活発化
  • セルフメディケーションの継続的な動向と疾患に対する認識
• 市場の課題
  • デバイスの受容性の低下、標準的な規制承認の欠如

ポーターの5つの力：胃食道逆流症治療器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：胃食道逆流症治療器市場における外部からの影響の把握

外部マクロ環境要因は、胃食道逆流症治療器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析胃食道逆流症治療器市場における競合情勢の把握

胃食道逆流症治療器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス胃食道逆流症治療器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、胃食道逆流症治療器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨胃食道逆流症治療器市場における成功への道筋を描く

胃食道逆流症治療器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢化が進む
    • 肥満人口の増加と手術への嗜好
    • 診断センターや個人クリニックでの導入が急増
  • 抑制要因
    • プロトンポンプ阻害剤などの代替薬の利用可能性
  • 機会
    • 強力なイノベーションと市場への新しい先進製品の投入
    • 自己治療の継続的な傾向と病気に対する意識
  • 課題
    • デバイスの受容性の低下、標準的な規制承認の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 胃食道逆流症治療器市場：製品タイプ別

• 診断装置
• 食道鏡と胃カメラ
• 噴門形成術用器具
• マノメトリーシステム
• PHモニタリングシステム
• 高周波アブレーション装置
• 括約筋増強装置
• 治療機器
• 超音波外科用エンドステープラー

第7章 胃食道逆流症治療器市場手順の種類別

• 診断手順
• 噴門形成術
• 磁気括約筋増強
• 高周波熱アブレーション

第8章 胃食道逆流症治療器市場手術の種類別

• 侵襲的
  • リンクス逆流症管理
  • メディガス超音波外科用エンドステープラー
• 非侵襲的
  • 内腔内胃瘻形成術
  • 内視鏡的ひだ形成システム
  • エソフィエックス
  • プレキシガラスポリメチルメタクリレートマイクロスフィア
  • ストレッタ

第9章 胃食道逆流症治療器市場デバイスタイプ別

• Bravo逆流検査システム
• デジトラッパー逆流検査システム
• LINX管理システム
• MUSE-Medigus超音波外科用エンドステープラー
• ストレッタ療法

第10章 胃食道逆流症治療器市場剤形別

• 液体
• 固体

第11章 胃食道逆流症治療器市場：投与経路別

• オーラル
• 非経口

第12章 胃食道逆流症治療器市場：エンドユーザー別

• 政府
• 病院
• 医療従事者

第13章 南北アメリカの胃食道逆流症治療器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の胃食道逆流症治療器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの胃食道逆流症治療器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Addex Pharmaceuticals Ltd.
• Aros Pharma ApS
• AstraZeneca PLC
• C. R. Bard, Inc.
• Eisai Co., Ltd.
• EndoGastric Solutions, Inc.
• Frost & Sullivan Inc.
• Johnson & Johnson Services, Inc.
• KARL STORZ SE & Co. KG
• MediGus Ltd.
• Olympus Corporation
• PENTAX Europe GmbH
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• The Procter & Gamble Company

LIST OF FIGURES

• FIGURE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES & GASTROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 82. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 83. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 85. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 129. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 130. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 132. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 138. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 139. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 141. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 184. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 186. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 192. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 201. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 202. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 204. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 205. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 210. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 211. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 213. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 214. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 219. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 220. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 222. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 237. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 238. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 239. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 240. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 241. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 242. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 246. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 247. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 248. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 249. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 250. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 251. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 255. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 256. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 257. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 258. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 259. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 264. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 265. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 266. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 267. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 268. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 269. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 273. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 274. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 275. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 277. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 278. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 283. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE,

The Gastroesophageal Reflux Disease Devices Market was valued at USD 5.85 billion in 2023, expected to reach USD 6.65 billion in 2024, and is projected to grow at a CAGR of 13.66%, to USD 14.35 billion by 2030.

The Gastroesophageal Reflux Disease (GERD) Devices market encompasses a range of medical devices aimed at diagnosing and treating GERD, a condition characterized by the backflow of stomach acid into the esophagus causing symptoms like heartburn and acid reflux. The necessity of these devices lies in the increasing prevalence of GERD, driven by factors such as lifestyle changes, obesity, and dietary habits. Their application extends across diagnostic endoscopy, pH monitoring for acid exposure, magnetic sphincter augmentation, and radiofrequency ablation, addressing patient needs from mild to severe reflux symptoms. End-use segments include hospitals, ambulatory surgical centers, and specialty clinics where the demand for minimally invasive solutions is rising. Key growth factors include advancements in endoscopic procedures, increased awareness of GERD complications, and supportive healthcare policies favoring device adoption. Market opportunities are expanding with technological innovations in device precision and patient comfort, and geographic expansion in emerging markets with rising healthcare infrastructure. To capture these opportunities, companies should focus on R&D in non-invasive diagnostics and treatment methods, customized device designs, and strategic partnerships to widen global outreach. However, the market faces limitations due to high costs of advanced devices, stringent regulatory approvals, and the availability of alternative treatment methods like medication and lifestyle modification, which might inhibit device adoption. Innovation could be directed towards developing cost-effective, patient-friendly diagnostic tools and exploring AI and machine learning for GERD monitoring solutions. The market is competitive with players focusing on product differentiation and patient outcomes, making it crucial for companies to continuously innovate and align with healthcare provider needs. Developing educational initiatives around GERD management could enhance end-user awareness and drive market penetration, fostering overall growth in the GERD devices sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising aging population across the world
  • Growing obese population and their preference for surgeries
  • Surge in adoption among diagnostic centers and private clinics
• Market Restraints
  • Availability of alternative such as proton pump inhibitors
• Market Opportunities
  • Robust innovation and launch of new advanced products in the market
  • Ongoing trend of self-medication and awareness of the disease
• Market Challenges
  • Decreased acceptability of devices an dearth of standard regulatory approval

Porter's Five Forces: A Strategic Tool for Navigating the Gastroesophageal Reflux Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastroesophageal Reflux Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastroesophageal Reflux Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastroesophageal Reflux Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastroesophageal Reflux Disease Devices Market

A detailed market share analysis in the Gastroesophageal Reflux Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastroesophageal Reflux Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastroesophageal Reflux Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastroesophageal Reflux Disease Devices Market

A strategic analysis of the Gastroesophageal Reflux Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage

This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.
• Based on Procedure Type, market is studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.
• Based on Surgery Type, market is studied across Invasive and Non-Invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-Invasive is further studied across Endocinch Endolumminal Gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas Poly-Methyl-Methacrylate Microspheres, and Stretta.
• Based on Device Type, market is studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, and Stretta Therapy.
• Based on Dosage Form, market is studied across Liquid and Solid.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on End-User, market is studied across Government, Hospitals, and Medical Practitioners.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising aging population across the world
    • 5.1.1.2. Growing obese population and their preference for surgeries
    • 5.1.1.3. Surge in adoption among diagnostic centers and private clinics
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative such as proton pump inhibitors
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust innovation and launch of new advanced products in the market
    • 5.1.3.2. Ongoing trend of self-medication and awareness of the disease
  • 5.1.4. Challenges
    • 5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gastroesophageal Reflux Disease Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostic Devices
• 6.3. Esophagoscopes & Gastroscopes
• 6.4. Fundoplication Devices
• 6.5. Manometry System
• 6.6. PH Monitoring System
• 6.7. Radiofrequency Ablation Devices
• 6.8. Sphincter Augmentation Devices
• 6.9. Treatment Devices
• 6.10. Ultrasonic Surgical Endostapler

7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Diagnostic Procedures
• 7.3. Fundoplication Procedures
• 7.4. Magnetic Sphincter Augmentation
• 7.5. Radiofrequency Thermal Ablation

8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type

• 8.1. Introduction
• 8.2. Invasive
  • 8.2.1. Linx Reflux Management
  • 8.2.2. Medigus Ultrasonic Surgical Endostapler
• 8.3. Non-Invasive
  • 8.3.1. Endocinch Endolumminal Gastroplication
  • 8.3.2. Endoscopic Plicator System
  • 8.3.3. EsophyX
  • 8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
  • 8.3.5. Stretta

9. Gastroesophageal Reflux Disease Devices Market, by Device Type

• 9.1. Introduction
• 9.2. Bravo Reflux Testing System
• 9.3. Digitrapper reflux testing system
• 9.4. LINX Management System
• 9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
• 9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form

• 10.1. Introduction
• 10.2. Liquid
• 10.3. Solid

11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration

• 11.1. Introduction
• 11.2. Oral
• 11.3. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, by End-User

• 12.1. Introduction
• 12.2. Government
• 12.3. Hospitals
• 12.4. Medical Practitioners

13. Americas Gastroesophageal Reflux Disease Devices Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Addex Pharmaceuticals Ltd.
• 2. Aros Pharma ApS
• 3. AstraZeneca PLC
• 4. C. R. Bard, Inc.
• 5. Eisai Co., Ltd.
• 6. EndoGastric Solutions, Inc.
• 7. Frost & Sullivan Inc.
• 8. Johnson & Johnson Services, Inc.
• 9. KARL STORZ SE & Co. KG
• 10. MediGus Ltd.
• 11. Olympus Corporation
• 12. PENTAX Europe GmbH
• 13. Pfizer Inc.
• 14. Takeda Pharmaceutical Company Limited
• 15. The Procter & Gamble Company